Immunoglobulin heavy variable 4-34-expressing B-cell receptor (IGHV4-34 BCR)

The IGHV4-34-expressing B-cell receptor is a specialized immunoglobulin receptor defined by the use of the IGHV4-34 heavy chain variable gene segment. This specific gene segment is notable for its intrinsic autoreactivity, as it possesses a germline-encoded ability to bind to the I/i carbohydrate antigens found on the surface of red blood cells and B cells. In healthy individuals, B cells expressing this receptor are usually strictly regulated or sequestered to prevent autoimmunity; however, their escape from tolerance is a hallmark of several pathological states. It is the primary driver of Cold Agglutinin Disease and is significantly overrepresented in the autoantibody repertoire of patients with Systemic Lupus Erythematosus (SLE). Additionally, IGHV4-34 expression is a defining feature of certain stereotyped subsets of Chronic Lymphocytic Leukemia (CLL) and is associated with specific clinical outcomes in B-cell lymphomas. Therapeutic intervention typically focuses on depleting the B-cell clones harboring this receptor or inhibiting the signaling pathways, such as those involving Bruton's tyrosine kinase (BTK), that allow these autoreactive cells to proliferate and survive.

Other names

VH4-34IGHV4-349G4 idiotype-positive B-cell receptor9G4+ BCRCold agglutinin-associated B-cell receptor

Targeting of B-cell populations expressing the IGHV4-34 receptor via B-cell depletion (anti-CD20) or inhibition of downstream B-cell receptor signaling (BTK inhibitors).